Highlights

BFM Podcast

Author: Tan KW   |   Latest post: Fri, 18 Jan 2019, 04:07 PM

 

Doctor in the House: Biosimilar Drugs – Making Cancer Treatment Affordable

Author:   |    Publish date:


Dr George Lee, Consultant Urologist | Datin Paduka Prof Dr Teo Soo Hwang, CEO, Cancer Research Malaysia

14-Dec-18 17:00

 

Dr George Lee returns to discuss the latest medical news. Expect deep insights delivered with generous humour. Earlier this week, the Health Ministry announced  that it has approved the biosimilar version of trastuzumab, a targeted therapy for women with HER2-positive breast cancer. The biosimilar version will significantly reduce the cost of treatment, which currently costs RM130,000 a year. Datin Paduka Prof Dr Teo Soo Hwang, CEO of Cancer Research Malaysia, joins us to discuss how biosimilar therapies can improve accessibility to cancer care.

 

Produced by: Tee Shiao Eek

Presented by: Meera Sivasothy

Share this

  Be the first to like this.
 


 

402  326  492  672 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ARMADA 0.22+0.06 
 SAPNRG 0.285-0.005 
 SUMATEC 0.005-0.01 
 MYEG 1.01-0.06 
 BARAKAH 0.08+0.02 
 NEXGRAM 0.020.00 
 IRIS 0.15+0.005 
 XINGHE 0.045+0.005 
 KNM 0.09+0.01 
 ECONBHD 0.515+0.045 

TOP ARTICLES

1. 火中取栗拼油气(下) 菜鸟必学7招/冷眼 【冷眼专栏】漫漫投资路
2. 当遇上基本面投资法(上) “反向”战略非唱反调/冷眼 【冷眼专栏】漫漫投资路
3. Stocks on Radar - AirAsia Group (5099) AmInvest Research Reports
4. FPI FY19 revenue growth expected to hit 15% FPI 2大因素前景看好台灣聯友今年再 尋突破
5. [转贴] 真实还原97亚洲金融风暴,韩国从暴富到破产仅用时7天! Good Articles to Share
6. Stocks on Radar - Elsoft Research (0090) AmInvest Research Reports
7. JAKS Resources Berhad - RM25.5m P&L Hit PublicInvest Research
8. THE PERCEPTION OF P/E or: How I learned to fear my Wife the bursa journey that worked for me. 2000-2019
Partners & Brokers